MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings Total Non Current Liabilities 2011-2026 | ZBH
Annual Total Non Current Liabilities Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 8.8 B | 10.4 B | 11.2 B | 14.6 B | 15.7 B | 2.07 B | 2.25 B | 2.28 B | 2.13 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.7 B | 2.07 B | 7.72 B |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 28.6 | -1.92 % | $ 1.32 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 12.19 | -3.02 % | $ 1.83 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 36.62 | -4.9 % | $ 5.46 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.63 | 2.92 % | $ 620 M |  Israel |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 9.51 | -0.94 % | $ 1.29 B | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.0 | -1.56 % | $ 203 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 40.21 | -2.9 % | $ 1.25 B | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.21 | -0.94 % | $ 157 M |  France |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.16 | -3.07 % | $ 109 M | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.48 | -0.48 % | $ 121 M | USA |
 |
Accuray Incorporated
ARAY
|
196 M | $ 0.49 | -2.39 % | $ 50.4 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.82 | 1.35 % | $ 44.6 M | USA |
 |
Align Technology
ALGN
|
184 M | $ 173.34 | -1.29 % | $ 13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
25.7 B | $ 109.92 | -0.95 % | $ 191 B | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 98.53 | -1.57 % | $ 1.25 B | USA |
 |
Inogen
INGN
|
52.5 M | $ 6.46 | -1.37 % | $ 172 M | USA |
 |
InMode Ltd.
INMD
|
12.5 M | $ 13.26 | -1.45 % | $ 857 M | Israel |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 71.46 | -2.09 % | $ 106 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 18.05 | 1.29 % | $ 423 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.24 | -10.14 % | $ 20 M | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 2.03 | 25.78 % | $ 79.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.17 | -3.55 % | $ 1.32 M | USA |
 |
Medtronic PLC
MDT
|
29.6 B | $ 90.96 | -2.2 % | $ 117 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 82.03 | -2.21 % | $ 48 B | USA |